Ocular Oncology News

BALTIMORE — Early detection and treatment and close long-term surveillance are critical for the management of choroidal nevus and melanoma, two experts told colleagues here.

BALTIMORE — Early detection and treatment and close long-term surveillance are critical for the management of choroidal nevus and melanoma, two experts told colleagues here.

The U.S. Food and Drug Administration has granted orphan drug designation to Icon Bioscience for melphalan intraocular injection, its investigational product for treatment of retinoblastoma, according to a company news release.

The direct costs of retinoblastoma treatment pose acute economic stress on families in China, according to a study.

CHICAGO — Novel and advanced technologies are critical for the evaluation and management of patients with ocular malignancies, a speaker said here.

Tarsal tumor location, positive surgical margins and other factors were associated with an increased risk of recurrence of ocular surface squamous neoplasia after surgical resection, according to a study.

Combined use of carboplatin, topotecan and melphalan in selective intra-arterial chemotherapy successfully rescued eyes with intraocular retinoblastoma after failure of intravenous chemotherapy and/or selective intra-arterial chemotherapy with a single or double agent, according to a study.

Failure to detect or correctly diagnose uveal melanoma may delay treatment and increase the need for enucleation, according to a large study.

Baerveldt shunts reduced IOP in eyes that underwent previous anterior segment irradiation for anterior uveal melanoma, according to a study.

Class 2 uveal melanomas demonstrated a higher tumor-related mortality rate and were linked to thicker tumors, older patient age and epithelioid pathology, but no definitive clinical markers could be found to differentiate class 1 and class 2 tumors, according to a study.